Guangdong VTR Bio-Tech Co Ltd Working Capital to Net Assets Ratio
Guangdong VTR Bio-Tech Co Ltd working capital to net assets ratio. Guangdong VTR Bio-Tech Co Ltd (300381) has a Working Capital to Net Assets ratio of 32.2% as of March 2026. Working capital of CN¥841.74 Million (current assets of CN¥1.06 Billion minus current liabilities of CN¥215.44 Million) is measured against net assets of CN¥2.61 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Guangdong VTR Bio-Tech Co Ltd (2007–2025)
Working capital to net assets ratio of Guangdong VTR Bio-Tech Co Ltd from 2007 to 2025. This chart shows how Guangdong VTR Bio-Tech Co Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 32.2%, reflecting working capital of CN¥841.74 Million against net assets of CN¥2.61 Billion CNY. Explore how much of Guangdong VTR Bio-Tech Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Guangdong VTR Bio-Tech Co Ltd Working Capital to Net Assets Ratio by Year (2007–2025)
Guangdong VTR Bio-Tech Co Ltd working capital to net assets ratio by year from 2007 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Guangdong VTR Bio-Tech Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Guangdong VTR Bio-Tech Co Ltd asset portfolio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 32.0% | CN¥829.01 Million | CN¥2.59 Billion | CN¥1.11 Billion | CN¥279.41 Million | ▼ -7.2 pp |
| 2024 | 39.2% | CN¥1.04 Billion | CN¥2.65 Billion | CN¥1.28 Billion | CN¥242.62 Million | ▼ -11.4 pp |
| 2023 | 50.7% | CN¥1.39 Billion | CN¥2.74 Billion | CN¥1.69 Billion | CN¥308.86 Million | ▼ -13.0 pp |
| 2022 | 63.7% | CN¥1.79 Billion | CN¥2.82 Billion | CN¥2.04 Billion | CN¥248.70 Million | ▲ +38.0 pp |
| 2021 | 25.8% | CN¥784.90 Million | CN¥3.05 Billion | CN¥1.95 Billion | CN¥1.17 Billion | ▼ -3.0 pp |
| 2020 | 28.7% | CN¥937.98 Million | CN¥3.26 Billion | CN¥2.08 Billion | CN¥1.15 Billion | ▼ -5.2 pp |
| 2019 | 34.0% | CN¥926.77 Million | CN¥2.73 Billion | CN¥2.04 Billion | CN¥1.12 Billion | ▼ -13.6 pp |
| 2018 | 47.6% | CN¥1.14 Billion | CN¥2.41 Billion | CN¥2.59 Billion | CN¥1.44 Billion | ▲ +31.7 pp |
| 2017 | 15.8% | CN¥331.10 Million | CN¥2.09 Billion | CN¥1.72 Billion | CN¥1.39 Billion | ▼ -10.8 pp |
| 2016 | 26.6% | CN¥546.61 Million | CN¥2.05 Billion | CN¥1.36 Billion | CN¥813.49 Million | ▲ +14.1 pp |
| 2015 | 12.5% | CN¥176.85 Million | CN¥1.42 Billion | CN¥941.83 Million | CN¥764.98 Million | ▼ -33.4 pp |
| 2014 | 45.9% | CN¥314.67 Million | CN¥685.38 Million | CN¥448.53 Million | CN¥133.86 Million | ▼ -0.4 pp |
| 2013 | 46.3% | CN¥141.58 Million | CN¥305.76 Million | CN¥196.38 Million | CN¥54.79 Million | ▼ -8.4 pp |
| 2012 | 54.7% | CN¥132.82 Million | CN¥242.72 Million | CN¥170.97 Million | CN¥38.16 Million | ▲ +3.3 pp |
| 2011 | 51.5% | CN¥96.74 Million | CN¥188.00 Million | CN¥159.46 Million | CN¥62.72 Million | ▲ +15.5 pp |
| 2010 | 36.0% | CN¥52.07 Million | CN¥144.81 Million | CN¥131.54 Million | CN¥79.47 Million | ▲ +15.4 pp |
| 2009 | 20.6% | CN¥25.47 Million | CN¥123.79 Million | CN¥93.08 Million | CN¥67.61 Million | ▲ +13.1 pp |
| 2008 | 7.5% | CN¥7.36 Million | CN¥98.12 Million | CN¥77.22 Million | CN¥69.86 Million | ▼ -25.4 pp |
| 2007 | 32.9% | CN¥25.55 Million | CN¥77.75 Million | CN¥69.04 Million | CN¥43.49 Million | — |